1 - The Food and Drug Administration cleared Ebb Insomnia Therapy (formerly Cereve) as a class II medical device indicated to reduce sleep latency to Stage 1 and Stage 2 sleep in patients with primary insomnia based on a de novo (new product) clearance request. Ebb is a prescription device.
2 - Nofzinger EA, et al. Regional cerebral metabolic correlates of WASO during sleep in insomnia. Journal of Clinical Sleep Medicine 2006; 2: 316-322
3 - Nofzinger EA, Miewald J, Price J, Buysse D. Frontal Cerebral Hypothermia: A New Approach to the Treatment of Insomnia. SLEEP. 2009; Abstract 0881
Join Our Priority List
Be the first to hear when Ebb Insomnia Therapy is available in your area!